Skip to content

Released Apr 29, 2020, after the close

10-Q filed Apr 30, 2020, 30 days after period end · 0001653477-20-000056

Q1 2020 · 10-Q
Revenue$288.20M+4.1% vs Q1 2019−5.0% vs Q4 2019
Net Income$45.30M+99.6% vs Q1 2019+2.3% vs Q4 2019
EPS Diluted$1.08+100.0% vs Q1 2019+2.9% vs Q4 2019
Gross Profit$114,600,000+18.0%
Operating Income$92,200,000+10.4%
Operating Cash Flow$60,200,000N/M
Free Cash Flowderived$40,700,000N/M
Margins · derived
Gross margin39.8%+4.7 pt vs Q1 2019
Operating margin32.0%+1.8 pt vs Q1 2019
Net margin15.7%+7.5 pt vs Q1 2019

What the release said

The release

Same quarter

MetricQ1 2020Q1 2019Q1 2018Q1 2017
Revenue$288.20M$276.80M$235.20M$218.50M
Net Income$45.30M$22.70M$30.80M$19.00M
EPS Diluted$1.08$0.54$0.72$0.45

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR